NEOS THERAPEUTICS, INC. Issuer AND [TRUSTEE], TrusteeIndenture • March 18th, 2019 • Neos Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 201 , among NEOS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
Neos Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 18th, 2019 • Neos Therapeutics, Inc. • Pharmaceutical preparations • New York
Neos Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
